as on January 23, 2026 at 2:29 am IST
Day's Low
Day's High
13.89%
Downside
-0.37%
Upside
52 Week's Low
52 Week's High
46.30%
Downside
43.15%
Upside
Check Altimmune Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$482.1M
EPS (TTM)
-0.9771
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-90.3M
Revenue (TTM)
20.0K
Profit Margin
0.00%
Return On Equity TTM
-52.62%
Compare market cap, revenue, PE, and other key metrics of Altimmune Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $482.1M | -62.51% | NA | 0.00% | |
| BUY | $48.3B | 114.64% | 1260.21 | 1.36% | |
| BUY | $118.2B | 96.7% | 32.47 | 31.35% | |
| NA | $37.8B | NA | 669.88 | 1.38% | |
| BUY | $79.4B | 40.49% | 17.95 | 32.13% |
The Altimmune Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Altimmune Inc investment value today
Current value as on today
₹82,741
Returns
Returns from Altimmune Inc Stock
Dollar Returns*
₹6,254 (+6.25%)
Based on 12 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 12 analysts, 75% of analysts recommend a 'BUY' rating for Altimmune Inc. Average target price of $17.75
Get share price movements and forecasts by analysts on Altimmune Inc.
What analysts predicted
69.58%UPSIDE
Target Price
$17.75
Current Price
$5.4
Analyzed by
12 Analysts
Target
$17.75
Altimmune Inc target price $17.75, a slight upside of 69.58% compared to current price of $5.4. According to 12 analysts rating.
Search interest for Altimmune Inc Stock has increased by 236% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:236% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, ALT stock has moved up by 26.9%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -22.14M → -19.01M (in $), with an average increase of 16.5% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 26.0% return, outperforming this stock by 89.1%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 52.5% return, outperforming this stock by 76.3%
Revenue Fall
![]()
Revenue is down for the last 9 quarters, 362.0K → 5.0K (in $), with an average decrease of 22.0% per quarter
| Organisation | Altimmune Inc |
| Headquarters | 910 Clopper Road, Gaithersburg, MD, United States, 20878 |
| Industry | Commercial Services |
| CEO | Mr. Jerome Benedict Durso |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. M. Scot Roberts Ph.D. | Chief Scientific Officer |
Mr. Jerome Benedict Durso | Chairman, CEO & President |
Mr. Andrew Shutterly M.S. | Principal Financial & Accounting Officer and Corporate Controller |
Mr. Bertrand Georges Ph.D. | Chief Technology Officer |
Mr. Tony Blandin B.S. | Vice President of Quality & Compliance Management |
Ms. Robin E. Abrams J.D. | General Counsel & Chief Legal Officer |
Ms. Linda M. Richardson | Chief Commercial Officer |
Mr. Gregory L. Weaver CPA, M.B.A. | Chief Financial Officer |
Mr. Raymond M. Jordt M.B.A. | Chief Business Officer |
Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D. | Chief Medical Officer |
Altimmune Inc share price today is $5.4 as on at the close of the market. Altimmune Inc share today touched a day high of $5.38 and a low of $4.65.
Altimmune Inc share touched a 52 week high of $7.73 on and a 52 week low of $2.9 on . Altimmune Inc stock price today i.e. is closed at $5.4,which is 30.14% down from its 52 week high and 86.21% up from its 52 week low.
Altimmune Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Altimmune Inc (ALT) shares with as little as ₹91.862 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.62 in Altimmune Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Altimmune Inc share’s latest price of $5.4 as on January 23, 2026 at 2:29 am IST, you will get 1.8519 shares of Altimmune Inc. Learn more about
fractional shares .
Altimmune Inc stock has given -62.51% share price returns and 24.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?